Abstract

Observational Study

Prescribing Inertia or Not? Quantitative Investigation of Loop Diuretics Prescribing after Palliative Care Consultation among Patients with Heart Failure

Zidong Zhang*, William Frick, Leslie Hinyard and Divya S Subramaniam

Published: 27 August, 2024 | Volume 9 - Issue 2 | Pages: 135-141

Purpose: Loop Diuretics (LD) are the first-line pharmacotherapy to address Heart Failure (HF)-associated edema and dyspnea. However, LD causes frequent urinary, resulting in inconvenience and possibly undermining the quality of life. While prescription adjustment is an essential part of Palliative Care Consultation (PCC), it remains unclear how PCC affects the deprescribing of diuretics for adults with HF. 
Methods: We conducted a pre-post analysis of the percentage of HF patients who were prescribed LD in a national Electronic Health Record (EHR) database 12 months before and after the first PCC. The difference in prescription rates between the periods was determined. Adjusted associations of post-PCC LD prescription with pre-PCC LD prescription and patient’s characteristics, insurance, provider type, and clinical factors were quantified.
Results: From 2010 to 2018, 5,969 patients with newly diagnosed HF received at least one PCC, among whom 2,539 (42.5%) were prescribed LD before and 1,552 (26.0%) after their first PCC. Despite a decrease in LD prescription rate encompassing the date of PCC, post-PCC LD prescribing was strongly associated with pre-PCC prescribing (aOR[95%CI] 3.2[2.8,3.7]) and varied by age at first PCC, year of HF diagnosis (aOR[95%CI] 2.1[1.9,2.4]) and months from HF diagnosis to first PCC. While our finding demonstrates reduced polypharmacy associated with PCC, the strong association between pre- and post-PCC indicates reverse therapeutic inertia. Future research should investigate the benefits and costs of polypharmacy among specific patient groups to help develop personalized treatment for HF.

Read Full Article HTML DOI: 10.29328/journal.jccm.1001194 Cite this Article Read Full Article PDF

Keywords:

Heart failure; Polypharmacy; Palliative care; Deprescribing; Diuretics; Clinical inertia

References

  1. Warraich HJ, Wolf SP, Mentz RJ, Rogers JG, Samsa G, Kamal AH. Characteristics and Trends Among Patients With Cardiovascular Disease Referred to Palliative Care. JAMA Netw Open. 2019;2(5):e192375. Available from: https://doi.org/10.1001/jamanetworkopen.2019.2375
  2. McIlvennan CK, Allen LA. Palliative care in patients with heart failure. BMJ. 2016;14;353:i1010.. Available from: https://doi.org/10.1136/bmj.i1010
  3. Goldberg RJ, Spencer FA, Szklo-Coxe M, Tisminetzky M, Yarzebski J, Lessard D, et al. Symptom presentation in patients hospitalized with acute heart failure. Clin Cardiol. 2010;33(6). Available from: https://doi.org/10.1002/clc.20627
  4. Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18):e895-e1032. Available from: https://doi.org/10.1161/cir.0000000000001063
  5. Faselis C, Arundel C, Patel S, Lam PH, Gottlieb SS, Zile MR, et al. Loop diuretic prescription and 30-day outcomes in older patients with heart failure. J Am Coll Cardiol. 2020;76(6):669-679. Available from: https://doi.org/10.1016/j.jacc.2020.06.022
  6. McGuinty C, Leong D, Weiss A, MacIver J, Kaya E, Hurlburt L, et al. Heart failure: A palliative medicine review of disease, therapies, and medications with a focus on symptoms, function, and quality of life. J Pain Symptom Manage. 2020;59(5):1127-46.e1. Epub 2019 Dec 24. Available from: https://doi.org/10.1016/j.jpainsymman.2019.12.357
  7. Brunner-La Rocca HP, Linssen GC, Smeele FJ, van Drimmelen AA, Schaafsma HJ, Westendorp PH, et al. Contemporary drug treatment of chronic heart failure with reduced ejection fraction: The CHECK-HF registry. JACC Heart Fail. 2019;7(1):13-21. Available from: https://doi.org/10.1016/j.jchf.2018.10.010
  8. Giugliano D, Maiorino MI, Bellastella G, Esposito K. Clinical inertia, reverse clinical inertia, and medication non-adherence in type 2 diabetes. J Endocrinol Invest. 2019;42(5):495-503. Available from: https://doi.org/10.1007/s40618-018-0951-8
  9. Girerd N, Von Hunolstein JJ, Pellicori P, Bayés-Genís A, Jaarsma T, Lund LH, et al. Therapeutic inertia in the pharmacological management of heart failure with reduced ejection fraction. ESC Heart Fail. 2022;9(4):2063-9. Available from: https://doi.org/10.1002/ehf2.13929
  10. Phillips LS, Branch WT, Cook CB, Doyle JP, El-Kebbi IM, Gallina DL, et al. Clinical inertia. Ann Intern Med. 2001;135(9):825-834. Available from: https://doi.org/10.7326/0003-4819-135-9-200111060-00012
  11. Mohottige D, Manley HJ, Hall RK. Less is more: Deprescribing medications in older adults with kidney disease: A review. Kidney360. 2021;2(9):1510-1522. Available from: https://doi.org/10.34067%2FKID.0001942021
  12. Verhestraeten C, Heggermont WA, Maris M. Clinical inertia in the treatment of heart failure: A major issue to tackle. Heart Fail Rev. 2021;26(6):1359-1370. Available from: https://link.springer.com/article/10.1007/s10741-020-09979-z
  13. Swat SA, Helmkamp LJ, Tietbohl C, Thompson JS, Fitzgerald M, McIlvennan CK, et al. Clinical inertia among outpatients with heart failure: Application of treatment nonintensification taxonomy to EPIC-HF trial. JACC Heart Fail. 2023;11(11):1579-1591. Available from: https://doi.org/10.1016/j.jchf.2023.06.022
  14. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2021;42(36):3599-3726. Available from: https://doi.org/10.1093/eurheartj/ehab368
  15. Warraich HJ, Rogers JG, Dunlay SM, Hummel E, Mentz RJ. Top ten tips for palliative care clinicians caring for heart failure patients. J Palliat Med. 2018;21(11):1646-1650. Available from: https://doi.org/10.1089/jpm.2018.0453
  16. Hill L, Prager Geller T, Baruah R, Beattie JM, Boyne J, de Stoutz N, et al. Integration of a palliative approach into heart failure care: a European Society of Cardiology Heart Failure Association position paper. Eur J Heart Fail. 2020;22(12):2327-2339. Available from: https://doi.org/10.1002/ejhf.1994
  17. Khan MZ, Khan MU, Munir MB. Trends and disparities in palliative care encounters in acute heart failure admissions; insight from National Inpatient Sample. Cardiovasc Revasc Med. 2021;23:52-56. Available from: https://doi.org/10.1016/j.carrev.2020.08.024
  18. Hua M, Li G, Clancy C, Morrison RS, Wunsch H. Validation of the V66.7 code for palliative care consultation in a single academic medical center. J Palliat Med. 2017;20(4):372-377. Available from: https://doi.org/10.1089/jpm.2016.0363
  19. Feder SL, Redeker NS, Jeon S, Schulman-Green D, Womack JA, Tate JP, et al. Validation of the ICD-9 diagnostic code for palliative care in patients hospitalized with heart failure within the Veterans Health Administration. Am J Hosp Palliat Med. 2018;35(7):959-965. Available from: https://doi.org/10.1177/1049909117747519
  20. Stubbs JM, Assareh H, Achat HM, Greenaway S, Muruganantham P. Verification of administrative data to measure palliative care at terminal hospital stays. Health Inf Manag J. 2023;52(1):28-36. Available from: https://doi.org/10.1177/1833358320968572
  21. Zhang Z, Lovell A, Subramaniam DS, Hinyard L. The impact of palliative care consultation on aggressive medical interventions in end-of-life among patients with metastatic breast cancer: Insights from the U.S. National Patient Sample. J Palliat Care. 2024;0(0):08258597241253933. Available from: https://doi.org/10.1177/08258597241253933
  22. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383. Available from: https://doi.org/10.1016/0021-9681(87)90171-8
  23. Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130-1139. Available from: https://doi.org/10.1097/01.mlr.0000182534.19832.83
  24. SAS Institute Inc. SAS/STAT® 15.3 User’s Guide: SAS Institute, Inc.; Cary, NC, USA; 2023. Available from: https://documentation.sas.com/doc/en/pgmsascdc/9.4_3.5/statug/titlepage.htm
  25. Buckley LF, Carter DM, Matta L, Cheng JW, Stevens C, Belenkiy RM, et al. Intravenous diuretic therapy for the management of heart failure and volume overload in a multidisciplinary outpatient unit. JACC Heart Fail. 2016;4(1):1-8. Available from: https://doi.org/10.1016/j.jchf.2015.06.017
  26. Felker GM, Lee KL, Bull DA, Redfield MM, Stevenson LW, Goldsmith SR, et al. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med. 2011;364(9):797-805. Available from: https://doi.org/10.1056/nejmoa1005419
  27. Granger BB, Tulsky JA, Kaufman BG, Clare RM, Anstrom K, Mark DB, et al. Polypharmacy in palliative care for advanced heart failure: The PAL-HF experience. J Card Fail. 2022;28(2):334-338. Available from: https://doi.org/10.1016/j.cardfail.2021.08.021
  28. Ginzburg R, Hilas O. Addressing clinical and therapeutic inertia through comprehensive medication review. Sr Care Pharm. 2022;37(9):412-420. Available from: https://doi.org/10.4140/tcp.n.2022.412
  29. Lebeau JP, Cadwallader JS, Aubin-Auger I, Mercier A, Pasquet T, Rusch E, et al. The concept and definition of therapeutic inertia in hypertension in primary care: a qualitative systematic review. BMC Fam Pract. 2014;15(1):130. Available from: https://doi.org/10.1186/1471-2296-15-130
  30. Reach G. Simplistic and complex thought in medicine: the rationale for a person-centered care model as a medical revolution. Patient Prefer Adherence. 2016;10:449-457. Available from: https://doi.org/10.2147%2FPPA.S103007
  31. Erhardt L, Komajda M, Hobbs FDR, Soler-Soler J. Cardiologists' awareness and perceptions of guidelines for chronic heart failure: The Address Your Heart survey. Eur J Heart Fail. 2008;10(10):1020-1025. Available from: https://doi.org/10.1016/j.ejheart.2008.08.001
  32. Calvin JE, Shanbhag S, Avery E, Kane J, Richardson D, Powell L. Adherence to evidence-based guidelines for heart failure in physicians and their patients: Lessons from the Heart Failure Adherence Retention Trial (HART). Congest Heart Fail. 2012;18(2):73-78. Available from: https://doi.org/10.1111/j.1751-7133.2011.00263.x
  33. Teixeira A, Arrigo M, Tolppanen H, Gayat E, Laribi S, Metra M, et al. Management of acute heart failure in elderly patients. Arch Cardiovasc Dis. 2016;109(6):422-430. Available from: https://doi.org/10.1016/j.acvd.2016.02.002
  34. Kavalieratos D, Gelfman LP, Tycon LE, Riegel B, Bekelman DB, Ikejiani DZ, et al. Palliative care in heart failure: Rationale, evidence, and future priorities. J Am Coll Cardiol. 2017;70(15):1919-1930. Available from: https://doi.org/10.1016/j.jacc.2017.08.036
  35. Frayne SM, Miller DR, Sharkansky EJ, Jackson VW, Wang F, Halanych JH, et al. Using administrative data to identify mental illness: What approach is best? Am J Med Qual. 2010;25(1):42-50. Available from: https://doi.org/10.1177/1062860609346347
  36. Solberg LI, Engebretson KI, Sperl-Hillen JM, Hroscikoski MC, O'Connor PJ. Are claims data accurate enough to identify patients for performance measures or quality improvement? The case of diabetes, heart disease, and depression. Am J Med Qual. 2006;21(4):238-245. Available from: https://doi.org/10.1177/1062860606288243
  37. Chang YK, Kaplan H, Geng Y, Mo L, Philip J, Collins A, et al. Referral criteria to palliative care for patients with heart failure: A systematic review. Circ Heart Fail. 2020;13(9):e006881. Available from: https://doi.org/10.1161/circheartfailure.120.006881
  38. Chang YK, Philip J, Allen LA, McClung JA, Hui D. Criteria that promote timely referral to specialist palliative care for patients with advanced heart failure. J Card Fail. 2024;30(1):85-90. Available from: https://doi.org/10.1016/j.cardfail.2023.07.011
  39. Messias E, Salas J, Scherrer JF. Patient characteristics prior to suicide attempts among Hispanics compared to non-Hispanic whites in the United States. J Affect Disord. 2022;308:130-133. Available from: https://doi.org/10.1016/j.jad.2022.04.068
  40. Scherrer JF, Salas J, Miller-Matero LR, Sullivan MD, Ballantyne JC, Debar L, et al. Long-term prescription opioid users' risk for new-onset depression increases with frequency of use. Pain. 2022;163(8):1581-1589. Available from: https://doi.org/10.1097/j.pain.0000000000002547
  41. Cooke CR, Joo MJ, Anderson SM, Lee TA, Udris EM, Johnson E, et al. The validity of using ICD-9 codes and pharmacy records to identify patients with chronic obstructive pulmonary disease. BMC Health Serv Res. 2011;11(1):37. Available from: https://doi.org/10.1186/1472-6963-11-37
  42. Gothe H, Rajsic S, Vukicevic D, Schoenfelder T, Jahn B, Geiger-Gritsch S, et al. Algorithms to identify COPD in health systems with and without access to ICD coding: A systematic review. BMC Health Serv Res. 2019;19(1):737. Available from: https://doi.org/10.1186/s12913-019-4574-3

Figures:

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?